| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 17/01/2019 | 10h00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 17/01/2019 | 10h00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 02/07/2018 | 22h49 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/06/2018 | 01h35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 23h23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 15h13 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 15h03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14h59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14h54 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14h48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14h31 | PR Newswire (US) | Lilly Completes Acquisition of ARMO BioSciences | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 18/06/2018 | 23h06 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/06/2018 | 23h04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/06/2018 | 22h27 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 11/06/2018 | 14h31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 30/05/2018 | 23h05 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 30/05/2018 | 23h03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/05/2018 | 15h18 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/05/2018 | 14h49 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/05/2018 | 22h52 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 14/05/2018 | 17h38 | PR Newswire (US) | WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |